+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Emphysema Drug"

Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 43 Pages
  • Global
From
Emphysema Treatment Market by Medication Type, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Emphysema Treatment Market by Medication Type, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • December 2022
  • 210 Pages
  • Global
From
Loading Indicator

The Emphysema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat emphysema, a chronic lung disease that causes shortness of breath, coughing, and wheezing. These drugs are typically inhaled corticosteroids, bronchodilators, and phosphodiesterase-4 inhibitors. They are used to reduce inflammation, open airways, and improve breathing. The Emphysema Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Other companies, such as Sunovion, Teva Pharmaceuticals, and Mylan, also offer products in this market. Show Less Read more